Clinical Trial Update: Down Syndrome Biomarker Initiative (DSBI)

View source ↗

Summary

The Down Syndrome Biomarker Initiative (DSBI) trial has completed, documenting biomarker findings in individuals with Down syndrome and Alzheimer's disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease
• Down Syndrome

Snippet

Sponsor: Michael Rafii | Conditions: Down Syndrome, Alzheimer's Disease | Status: COMPLETED